# Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/reporting-drug-sample-information-under-section-6004-of-the-affordable-care-act/324bb7a2-737c-4021-a1b4-e156ceed5ab8

> FDA guidance document: Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act. Issue date: July 11, 2014. Get complete insights and analysis.

---

## Details

- Title: Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2014-07-11
- Last Changed: 2020-04-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-0829">FDA-2014-D-0829</a>

## Related Documents

- [Malaria: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/malaria-developing-drugs-for-treatment-draft-guidance-for-industry/3edfcacf-7736-421e-9b04-b883ec5cc173)
- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)
- [DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers](https://www.globalkeysolutions.net/guidances/guidance-document/dscsa-implementation-annual-reporting-by-prescription-drug-wholesale-distributors-and-third-party-logistics-providers/712ebdd8-de0d-4a6d-b6c3-0983093ca377)